SAFETY AND IMMUNOGENICITY OF VARICELLA-ZOSTER VIRUS (VZV) VACCINE IN ADULTS

被引:0
|
作者
KUMAR, ML
COLLINS, MS
GOPALAKRISHNA, KV
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106
[2] CLEVELAND METROPOLITAN GEN HOSP,CLEVELAND,OH 44109
[3] FAIRVIEW GEN HOSP,DEPT PEDIAT,CLEVELAND,OH 44111
[4] FAIRVIEW GEN HOSP,DEPT MED,CLEVELAND,OH 44111
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:A313 / A313
页数:1
相关论文
共 50 条
  • [1] Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults with Autoimmune Disease
    McAdam, Lawrence
    Eberhardson, Michael
    Grainger, William
    Papp, Kim
    Hall, Stephen
    Sterling, Tina
    Stek, Jon
    Pang, Lei
    Zhao, Yanli
    Chan, Ivan
    Haupt, Richard
    Parrino, Janie
    Silber, Jeffrey
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3327 - 3327
  • [2] Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults
    Macaladad, N.
    Marcano, T.
    Guzman, M.
    Moya, J.
    Jurado, F.
    Thompson, M.
    Meechan, C.
    Li, D.
    Schlienger, K.
    Chan, I.
    Sadoff, J.
    Schodel, E.
    Silber, J. L.
    [J]. VACCINE, 2007, 25 (11) : 2139 - 2144
  • [3] Immunogenicity & safety of varicella-zoster virus (VZV) vaccine administered to older adults with or without diabetes mellitus (DM) or chronic obstructive pulmonary disease (CORD).
    Schmader, K
    Bobrove, A
    Levin, M
    Oxman, M
    Tucker, R
    Reisinger, K
    Nunez, M
    Rothbaum, J
    Johnson, P
    Stek, J
    Thompson, M
    Rafalowski, M
    Klopfer, S
    Chan, C
    Sadoff, J
    Chan, I
    Silber, J
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (04) : S165 - S165
  • [4] VARICELLA-ZOSTER VIRUS (VZV) SPECIFIC CYTOTOXICITY AFTER IMMUNIZATION OF NONIMMUNE ADULTS WITH OKA STRAIN ATTENUATED VZV VACCINE
    HAYWARD, A
    VILLANUEBA, E
    COSYNS, M
    LEVIN, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02): : 260 - 264
  • [5] Vaccines against varicella-zoster virus (VZV)
    Salleras, Luis
    Salleras, Montserrat
    Soldevila, Nuria
    Prat, Andreu
    Garrido, Patricio
    Dominguez, Angela
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (06): : 411 - 423
  • [6] Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients
    Weinberg, A
    Horslen, SP
    Kaufman, SS
    Jesser, R
    DeVoll-Zabrocki, A
    Fleckten, BL
    Kochanowicz, S
    Seipel, KR
    Levin, MJ
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (03) : 565 - 568
  • [7] Immunogenicity of the whole antigen and glycoprotein I of Varicella-zoster virus (VZV) and the VZV skin test antigen
    Kawano, S
    Terada, K
    Hiraga, Y
    Morita, T
    [J]. ACTA PAEDIATRICA JAPONICA, 1996, 38 (02): : 121 - 123
  • [8] Varicella-zoster virus vaccine
    White, CJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 753 - 761
  • [9] CHARACTERIZATION AND IMMUNOGENICITY OF A CANDIDATE SUBUNIT VACCINE AGAINST VARICELLA-ZOSTER VIRUS
    DAVIES, J
    HALLWORTH, JA
    MCLEISH, P
    RANDALL, S
    MARTIN, BAB
    BUCHAN, A
    SKINNER, GRB
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1994, 183 (02) : 105 - 117
  • [10] Issues in varicella-zoster virus (VZV) ganglionic latency
    Kennedy, Peter G.
    [J]. JOURNAL OF NEUROVIROLOGY, 2006, 12 : 38 - 39